Initial Therapy of Panretinal Photocoagulation vs Anti-VEGF Injection for Proliferative Diabetic Retinopathy
In this retrospective cohort study, findings suggest that patients with PDR treated with PRP first then subsequent anti-VEGF injection are more likely to undergo PPV for VH and TRD compared with matched patients treated with anti-VEGF agents first, then PRP. These findings support the need for further investigations to determine if the order of PRP and anti-VEGF injections should be considered when treating patients with PDR.
Authors
- Euna B. Koo (ORCID: https://orcid.org/0000-0003-4218-3338)
- Prithvi Mruthyunjaya (ORCID: https://orcid.org/0000-0003-1087-9736)
- Ravi Parikh (ORCID: https://orcid.org/0000-0003-3369-4224)
- Karen M. Wai (ORCID: https://orcid.org/0000-0001-8980-2242)
- Amer F. Alsoudi (ORCID: https://orcid.org/0000-0002-2492-1993)
- Ehsan Rahimy (ORCID: https://orcid.org/0000-0001-8446-7078)
Institutions
- Baylor College of Medicine (US)
- NYU Langone Health (US)
- Palo Alto Institute (US)
- Smith-Kettlewell Eye Research Institute (US)
- Stanford University (US)
Publication Details
- Journal
- JAMA Ophthalmology
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1001/jamaophthalmol.2024.3283
- Citations
- 22
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 11.85